Chinese guidelines for minimally invasive donor hepatectomy in living donor liver transplantation (2024 edition)
Xi Xu(Brigham and Women's Hospital), Tingbo Liang(RTI International), Qian Lü(Maternal and Child Health Care Hospital of Bao'an), Shichun Lu(Chinese PLA General Hospital), Jun Liu(Fujian Medical University), Jiakai Zhang(First Affiliated Hospital of Zhengzhou University), Jinzhen Cai(Qingdao University), Zhishui Chen(Tongji Hospital), Lei Huang(Shanghai Jiao Tong University), Chengyou Du(The Affiliated Yongchuan Hospital of Chongqing Medical University), Lin‐Hung Wei(Capital Medical University), Zuojin Liu(Dalian Medical University), Wentao Jiang(Tianjin First Center Hospital), Qiyong Li(Zhejiang Shuren University), Zhiyong Guo(Second Military Medical University), Shunda Du(Academy of Medical Sciences), Ying Cheng(Jilin Province Tumor Hospital), Feng Huo(General Hospital of Guangzhou Military Command), Changku Jia(Westlake University), Lianghui Gao(Hainan Medical University), Li Li(Chengdu Medical College), Ning Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Jianhua Li(Suizhou Central Hospital), Guangming Li(Shandong Iron and Steel Group (China)), Zuoyi Jiao(Lanzhou University Second Hospital), Tao� Lv(Sichuan University), Qiang He(Kanazawa Medical University), Jingfeng Liu(Fujian Medical University), Jin Chen(Central South University), Lei Liu(China Three Gorges University), Ren Lang(Beijing Chao-Yang Hospital, Capital Medical University), Ling Lv(Jiangsu Province Hospital), Guihua Chen(Sun Yat-sen University), Lianxin Liu(Southern University of Science and Technology), Jian Dou(Hebei Medical University), Qiang Wei(Chongqing Medical University), Wengang Li(First Affiliated Hospital of Xiamen University), Xiao-Shun He, Guoyue Lv(Jilin University), Yi Lv(First Affiliated Hospital of Xi'an Jiaotong University), Zhonghua Chen(Tongji Hospital), Jipin Jiang(Tongji Hospital), Qi Ling(First Affiliated Hospital Zhejiang University), Gang Xu(Zhejiang University), Jianzhao Huang(Guizhou Provincial People's Hospital), Bo Li(University of Medicine and Health Sciences), Yumin Li(Lanzhou University Second Hospital), Yang Cai(Westlake University), Zhi-ren Fu(Shanghai Jiao Tong University)
Cited by 2
Related Papers
Pembrolizumab plus Chemotherapy for Squamous Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2018|3.7k
Dacomitinib versus gefitinib as first-line treatment for patients with EGFR-mutation-positive non-small-cell lung cancer (ARCHER 1050): a randomised, open-label, phase 3 trial
|The Lancet Oncology|2017|1.2k